綠茶表沒食子酸酯型唲茶素酸酯對胰島素刺激前脂肪細胞增生的抑制; Inhibitory effect of green tea (-)-epigallocatechin gallate on insulin-stimulated mitogenesis of 3T3-L1 preadipocytes

NCU Institutional Repository > 生醫理工學院 > 生命科學研究所 > 博碩士論文 > Item 987654321/6402

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.lib.ncu.edu.tw/handle/987654321/6402

题名:	綠茶表沒食子酸酯型唲茶素酸酯對胰島素刺激前脂肪細胞增生的抑制;Inhibitory effect of green tea (-)-epigallocatechin gallate on insulin-stimulated mitogenesis of 3T3-L1 preadipocytes
作者:	劉咸君;Hsien-Chun Liu
贡献者:	生命科學研究所
关键词:	綠茶表沒食子酸酯型唲茶素酸酯;前脂肪細胞;胰島素;(-)-epigallocatechin gallate;insulin;3T3-L1 preadipocytes
日期:	2005-01-12
上传时间:	2009-09-22 10:18:56 (UTC+8)
出版者:	國立中央大學圖書館
摘要:	肥胖是一種常見的疾病，與癌症，糖尿病，高血壓以及心血管疾病都有相關。造成肥胖的原因是脂肪細胞數目的增加，或脂肪細胞內三酸甘油酯的堆積(泛稱脂肪細胞分化)使然。根據研究指出，內分泌與營養都會影響到肥胖的調節作用，其中胰島素在細胞分化時期會刺激細胞進行mitotic clonal expansion及adipogenesis，並促使細胞進行脂肪生成和抑制脂肪分解作用。然而綠茶唲茶素(亦稱維生素P)，尤其是綠茶表沒食子酸酯型唲茶素酸酯(英文名稱和簡稱分別為 (-)-epigallocatechin gallate和EGCG)，已被證實可以抑制脂肪細胞的增生與分化，並可促使前脂肪細胞和脂肪細胞的apoptosis，以及促進脂肪氧化作用，因此可視為預防肥胖的保健物質。有鑑於此，EGCG是否可調節胰島素刺激前脂肪細胞的增生仍然不清楚。在本論文中，使用3T3-L1前脂肪細胞株做為研究素材，我發現胰島素濃度在1-1000 nM，細胞數目和BrdU攝入皆有增加的情形，可以得知胰島素會刺激前脂肪細胞的增生。而胰島素的有效濃度EC50-100 在2- 4天的處理為100 nM。此外，由於胰島素可分別增加胰島素接受器、IRS-1和 Erk三種蛋白的磷酸化，可見胰島素分別增加胰島素接受器、IRS-1和MEK-1的活性。然而前處理EGCG (10-50 μM)於前脂肪細胞可以明顯抑制胰島素所促進的細胞數目、BrdU攝入、胰島素接受器的活性、IRS-1的活性、 MEK-1的活性及胰島素接受器與IRS-1兩者之間的結合作用。以上種種的跡象顯示，EGCG可透過阻礙胰島素的訊息傳導路徑而抑制前脂肪細胞的增生。 Obesity, a common disease resulting from mitogenesis and lipid accumulation (so-called adipogenesis) of fat cells, is associated with the risks of cancers, diabetes, hypertension, and cardiovascular disease. Development of obesity can be regulated by endocrine and nutritional cues based on a variety of laboratory studies. Insulin (INS) was reported to stimulate mitotic clonal expansion and adipogenesis during fat cell differentiation in additional to stimulating lipogenesis and inhibiting lipolysis. In contrast, green tea polyphenols (the so-called vitamin P), especially the catechin, (-)-epigallocatechin gallate (EGCG), was found to inhibit proliferation and differentiation of fat cells, to induce the apoptosis of preadipocytes and adipocytes, to stimulate fat oxidation, and to be proposed as an obesity chemopreventative. But, determining whether EGCG acts to regulate the stimulatory effect of INS on the mitogenesis of fat cells is still not clear. In this thesis using 3T3-L1 preadipocytes as the research cell model, I found that INS at 1-1000 nM could stimulate the growth of 3T3-L1 preadipocytes as indicated by increased cell number and BrdU incorporation. The EC50-100 of INS was about 100 nM after 2~4 days of treatment. Also, INS stimulated activities of INS receptor (INSR), insulin receptor substrate 1 (IRS-1), and MEK1, respectively, as indicated by increased phosphorylation of INSR, IRS-1, and Erk proteins. However, pretreatment of preadipocytes with EGCG (10-50 μM) resulted in significant decreases in the INS-induced increases in their cell number, BrdU incorporation, activities of INSR, IRS-1, and MEK-1, and the association of INSR with IRS-1. These data suggest that EGCG can inhibit preadipocyte mitogenesis by reduction of INS-mediated signaling in these cells.
显示于类别:	[生命科學研究所 ] 博碩士論文

文件中的档案:

档案	大小	格式	浏览次数

在NCUIR中所有的数据项都受到原著作权保护.

社群 sharing

数据加载中.....